荷兰临床实验室室内质量控制实践现状及指南制定起点
该研究向荷兰所有临床化学实验室发放含20道多选题的问卷,调查室内质量控制(iQC)实践及指南需求,共收到27家实验室回复(回复率43%)。结果显示iQC实践异质性大:30%仅基于分析特性,30%采用6-Sigma方法,19%采用基于风险的6-Sigma以上方法,22%采用替代方法;89%使用虚拟分析仪模型,44%使用患者移动均值。研究识别了SD值确定、虚拟分析仪模型和确保分析仪等效性等指南制定起点。
要点
- 荷兰临床实验室iQC实践异质性大,SD值确定方法多样。
- 89%实验室使用虚拟分析仪模型进行iQC设置。
- 44%实验室对一个或多个检测项目使用患者移动均值。
核心结论
- 荷兰临床实验室的iQC实践存在较大异质性,需在SD值确定、虚拟分析仪模型和分析仪等效性保障等方面制定指南和开展进一步研究。
研究设计与样本
- 向荷兰所有临床化学实验室发放含20道多选题的问卷,调查iQC实践及相关方面,结果以描述性方式报告。
- 共收到27家临床实验室回复,回复率43%。
主要发现
- 30%的实验室iQC仅基于分析特性,30%使用6-Sigma方法,19%使用基于风险的6-Sigma以上方法,22%使用替代方法。
- 89%的实验室在一个或多个实验室内使用虚拟分析仪模型进行iQC设置。
- 确定标准差(SD)值的方法包括:35%为每种新iQC材料确定SD,35%对新材料使用历史SD值,31%将临床允许误差纳入SD值。
- 44%的实验室对一个或多个检测项目使用患者移动均值。
关键数值与推荐
- 每日iQC管理基于指示在控或失控状态的「交通灯」以及所有质控图审核,常使用多个软件系统。
临床怎么用
- 临床实验室可参考本调查中iQC实践异质性,审视自身SD值确定、虚拟分析仪模型使用及患者移动均值应用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Adequate analytical quality of reported results is primarily ensured by performing internal quality control (iQC). Currently, several different iQC practices are in use. As a prelude to the revision of a Dutch guidance document on analytical QC, a questionnaire was sent out to gain insights in the applied practices and the need for guidance. METHODS: A questionnaire, containing 20 multiple-choice questions with possibilities for explanation and comment on iQC practices and aspects was distributed to all clinical chemistry laboratories within the Netherlands. Results were reported descriptively. RESULTS: Responses were received from 27 clinical laboratories (response 43 %). In 30 % the iQC was based on the analytical characteristics only, while 30 % used a 6-Sigma method, 19 % risk-based beyond 6-Sigma and 22 % used an alternative approach. 89 % of laboratories used a virtual analyzer model for iQC setup within one or more laboratory sites. Practices for determining standard deviation (SD) values included determining SD for each new iQC material (35 %), using historical SD values for new materials (35 %), and incorporating clinical tolerances into the SD value (31 %). Furthermore, 44 % of laboratories used patient moving averages for one or more tests. Daily iQC management was based on either "traffic lights" indicating in or out of control status, and review of all QC charts, often using multiple software systems. CONCLUSIONS: A large heterogeneity of iQC practices in clinical laboratories was observed in the Netherlands. Several starting points for further research and/or guidance were identified, particularly in relation to the determination of SD values, the virtual analyzer model and methods to ensure analyzer equivalence.
引用
- van Rossum HH, van Schrojenstein Lantman M, Severens M, et al. Quality control in the Netherlands; todays practices and starting points for guidance and future research. Clin Chem Lab Med. 2024. PMID: 38661089. doi:10.1515/cclm-2024-0316
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。